IRVINE, California, May 26, 2017 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, has received U.S. Federal Government clearance to receive U.S. Federal Government contracts.
Tag Archives: Irvine
CBIS Pushes Up the Seeding Schedule Next Month to 350 Acres Set to Include Additional 100 Acres in Minden Carson Valley Property Along with the San Joaquin Valley Property for its Industrial Commercial Hemp Grow Initiatives
IRVINE, Calif., April 17, 2017 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that it has negotiated a deal to begin seeding the 100 Acres in Minden County Nevada adding to the 250 acres of farm lands in the San Joaquin Valley, California for its Industrial Commercial Hemp Grow Initiatives.
CBIS and RCDU Sign Another Large California Cultivation Land Deal for Two Hundred and Fifty Acres, Scheduled to be Seeded all at Once for Maximum Harvest and Research Production
IRVINE, Calif., April 13, 2017 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that it has negotiated a deal with the Members of the Winnemucca Tribe Shoshoni MBS Fee Lands for 250 acres of HRM farm lands in the San Joaquin Valley, California.
CBIS Ramps Up Production and Releases More New Products to Meet the Substantial Requests From Self-Medicating Patients Across the Country as it Highlights Moonlight Cannabis as its Newest Spotlight Dispensary for the Month of April 2017
IRVINE, Calif., March 27, 2017 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to announce that it has substantially increased its production for its self-medicating patient product line distributed through cannabis dispensaries in California.
Cannabis Science Senior Executives to Co-Chair Special Session and Deliver a Keynote Speech at the Global Health Catalyst Summit at Harvard Medical School
IRVINE, Calif., March 1, 2017 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to announce that its President, CEO and Co-Founder, Raymond C. Dabney, will be a keynote speaker and panelist at the Global Health Catalyst (GHC) Summit at Harvard Medical School on April 28-30, 2017.
Cannabis Science Orders Multiple Greenhouse Structures for its 2nd Pilot 33,000 Sq. Ft. Drug Development Facility Buildout in Douglas County, Nevada
IRVINE, Calif., Dec. 21, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medications, has started work on its second 33,000 sq. ft. pilot cannabinoid drug development and manufacturing facility in Douglas County, Nevada.
Cannabis Science Signs a 320-Acre Allotment Property Development Deal in Humboldt County, Nevada with Members of the Winnemucca Tribal Allotments Led by Chief Bill
IRVINE, Calif., Oct. 26, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS) announced it has just signed a new agreement that will provide an additional 320 acres of allotment development land in Humboldt County, Nevada.
Cannabis Science Activates Its Critical Financial Security Department to Specialize in the Worldwide Industry Deficiency in Risk Mitigation, Banking, Payment Processing, and Cash and Asset Movement
IRVINE, Calif., Sept. 2, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to announce the development and opening of the Cannabis Science Financial Security Department.
Cannabis Science and the Research Foundation Begins Protocols for California Legal Patients to Receive the New CBIS MDI Rescue Inhaler for Its First Observational Study Intending to Lead Into Clinical Trials
IRVINE, Calif., Aug. 12, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is happy to announce the intent to seek out 20 - 25 potential candidates suffering from Asthma/COPD and other critical ailments.
Cannabis Science Orders First Batch Inhalation Medication and Adds CBIS MDI Rescue Inhaler for Asthma/COPD via Nebulizer, Targeting 25+ Legal States, and National Market Variables
IRVINE, Calif., Aug. 11, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis based medicines, is happy to announce their first batch order for the previously announced cannabinoid based inhalation medicine for Asthma/COPD has been placed.
Twenty Acre Indoor/Outdoor Cultivation Facility in Northern California in the Final Stages of Escrow Awaiting Transfer of Ownership to Cannabis Science, Inc.
IRVINE, Calif., Aug. 1, 2016/Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, today announced they are in the final stages of escrow to transfer the 20-acre Northern California cultivation property into its name and commence indoor/outdoor cultivation and production on the land.
Cannabis Science Develops Inhalation Medication for Those Suffering Asthma/COPD via Nebulizer, Targets National Markets
IRVINE, Calif., July 29, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to announce they will release an inhalation medication for those suffering asthma/COPD for use in patient nebulizers.
Cannabis Science 2016 Growth Guidance; Project Briefs, Cash-Flow Projections, and Current Historic Cannabis Industry Advancements; Industry Growth Indicators
IRVINE, Calif., July 20, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to provide its future operations and growth guidance based on its current projects, cash-flow projections, and current historic market advancements.
Cannabis Science Guidance; Corporate Headquarters Relocated to California as it Negotiates for a Los Angeles, California Laboratory/Medical Treatment Center
LOS ANGELES, June 30, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, today announced the relocation of their corporate headquarters to Irvine, California.
Weedmaps Partners with Cannabis Technology Company Green Bits on Point of Sale Integration
IRVINE, Calif., May 10, 2016 /Weed Wire/ — Weedmaps, the first and largest global technology and media company in the cannabis space, announced a new partnership with cannabis technology company Green Bits, a leader in point-of-sale (POS) and inventory management solutions.
iBrands Corp. Enters Into Cannabis Sector With Launch of “Purest” Whole Plant Extraction CBD Oil Products
IRVINE, Calif., May 6, 2016 /Weed Wire/ — iBrands (OTC PINK: IBRC) is pleased to announce the launch of “PUREST” product line of whole plant extraction CBD products.
Doug Francis Replaces Justin Hartfield as CEO of Weedmaps
On Feb. 23, 2016, Weedmaps, an online community connecting users to marijuana dispensaries, announced that Doug Francis had replaced Justin Hartfield as CEO of the company, with Hartfield now acting as board chairman for Weedmaps’ family of companies, including Marijuana.com.
3 Lids Consulting
3 Lids Consulting provides real estate services for dispensary buyers and sellers, evaluates properties and provides valuation on all property listings.